Synteract Inks Buy of Harrison Clinical
Posted on: December 19, 2012 by Luisa BeltranNo Comments »
Synteract, which is backed by Gryphon Investors, has agreed to buy Harrison Clinical Research. Financial terms were not announced. Munich, Germany-based Harrison is a clinical research company.





